Low ER+ Breast Cancer-Reference-Cited by-同舟云学术

Low ER+ Breast Cancer

Published:2014-05-01 Issue:5 Volume:141 Page:697-701
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Gloyeske Nika C.¹,Dabbs David J.¹,Bhargava Rohit¹

Affiliation:

1. Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/141/5/697/24997396/ajcpath141-0697.pdf

Reference24 articles.

1. Incidence of breast cancer in the United States: current and future trends;Anderson;J Natl Cancer Inst,2011

2. Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers;Bhargava;Int J Clin Exp Pathol,2009

3. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer;Hammond;J Clin Oncol,2010

4. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer;Cuzick;J Clin Oncol,2011

5. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer;Wolff;J Clin Oncol,2007

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center;The Breast;2024-06

2. Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significance;European Journal of Cancer;2024-01

3. The Clinical and Pathological Characteristics That Differentiate Cases With “Low Estrogen Receptor Expression” From Triple-Negative Breast Cancer;European Journal of Breast Health;2024-01-01

4. Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives;Current Oncology;2023-11-04

5. The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer;Modern Pathology;2023-10